JP2023515672A5 - - Google Patents

Info

Publication number
JP2023515672A5
JP2023515672A5 JP2022552551A JP2022552551A JP2023515672A5 JP 2023515672 A5 JP2023515672 A5 JP 2023515672A5 JP 2022552551 A JP2022552551 A JP 2022552551A JP 2022552551 A JP2022552551 A JP 2022552551A JP 2023515672 A5 JP2023515672 A5 JP 2023515672A5
Authority
JP
Japan
Prior art keywords
microrna
mir
binding site
vector
microrna binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022552551A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023515672A (ja
JP7865533B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/020032 external-priority patent/WO2021178246A1/en
Publication of JP2023515672A publication Critical patent/JP2023515672A/ja
Publication of JP2023515672A5 publication Critical patent/JP2023515672A5/ja
Priority to JP2026007624A priority Critical patent/JP2026076236A/ja
Application granted granted Critical
Publication of JP7865533B2 publication Critical patent/JP7865533B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022552551A 2020-03-02 2021-02-26 心筋細胞発現マイクロrnaによる遺伝子ベクター制御 Active JP7865533B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026007624A JP2026076236A (ja) 2020-03-02 2026-01-20 心筋細胞発現マイクロrnaによる遺伝子ベクター制御

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062984183P 2020-03-02 2020-03-02
US62/984,183 2020-03-02
PCT/US2021/020032 WO2021178246A1 (en) 2020-03-02 2021-02-26 Gene vector control by cardiomyocyte-expressed micrornas

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026007624A Division JP2026076236A (ja) 2020-03-02 2026-01-20 心筋細胞発現マイクロrnaによる遺伝子ベクター制御

Publications (3)

Publication Number Publication Date
JP2023515672A JP2023515672A (ja) 2023-04-13
JP2023515672A5 true JP2023515672A5 (cg-RX-API-DMAC7.html) 2024-03-05
JP7865533B2 JP7865533B2 (ja) 2026-05-26

Family

ID=75143738

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022552551A Active JP7865533B2 (ja) 2020-03-02 2021-02-26 心筋細胞発現マイクロrnaによる遺伝子ベクター制御
JP2026007624A Pending JP2026076236A (ja) 2020-03-02 2026-01-20 心筋細胞発現マイクロrnaによる遺伝子ベクター制御

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026007624A Pending JP2026076236A (ja) 2020-03-02 2026-01-20 心筋細胞発現マイクロrnaによる遺伝子ベクター制御

Country Status (10)

Country Link
US (1) US20230103731A1 (cg-RX-API-DMAC7.html)
EP (1) EP4114421A1 (cg-RX-API-DMAC7.html)
JP (2) JP7865533B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220149590A (cg-RX-API-DMAC7.html)
CN (1) CN115552022A (cg-RX-API-DMAC7.html)
AU (1) AU2021230476A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022017551A2 (cg-RX-API-DMAC7.html)
CA (1) CA3173567A1 (cg-RX-API-DMAC7.html)
IL (1) IL295989A (cg-RX-API-DMAC7.html)
WO (1) WO2021178246A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210102870A (ko) 2018-08-30 2021-08-20 테나야 테라퓨틱스, 인코포레이티드 미오카르딘 및 ascl1을 사용한 심장 세포 재프로그래밍
WO2025178388A1 (ko) * 2024-02-20 2025-08-28 가천대학교 산학협력단 통증 치료용 의약 조성물
WO2025219365A1 (en) * 2024-04-15 2025-10-23 BioNTech SE Repression of cargo expression
CN120754123A (zh) * 2025-08-15 2025-10-10 吉林大学第一医院 LncRNA XIST在制备预防血管紧张素II引起心肌损伤药物中的应用

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US7070994B2 (en) 1988-03-21 2006-07-04 Oxford Biomedica (Uk) Ltd. Packaging cells
US5591624A (en) 1988-03-21 1997-01-07 Chiron Viagene, Inc. Retroviral packaging cell lines
WO1990002806A1 (en) 1988-09-01 1990-03-22 Whitehead Institute For Biomedical Research Recombinant retroviruses with amphotropic and ecotropic host ranges
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
US5817491A (en) 1990-09-21 1998-10-06 The Regents Of The University Of California VSV G pseusdotyped retroviral vectors
US5384253A (en) 1990-12-28 1995-01-24 Dekalb Genetics Corporation Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
WO1993004169A1 (en) 1991-08-20 1993-03-04 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
ATE237694T1 (de) 1991-08-20 2003-05-15 Us Gov Health & Human Serv Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
US5702932A (en) 1992-07-20 1997-12-30 University Of Florida Microinjection methods to transform arthropods with exogenous DNA
DE4228457A1 (de) 1992-08-27 1994-04-28 Beiersdorf Ag Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
EP0673431A1 (en) 1992-12-03 1995-09-27 Genzyme Corporation Gene therapy for cystic fibrosis
US5834256A (en) 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
EP0705344B8 (en) 1993-06-24 2006-05-10 Advec Inc. Adenovirus vectors for gene therapy
DE69435223D1 (de) 1993-10-25 2009-09-03 Canji Inc Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung
US5656610A (en) 1994-06-21 1997-08-12 University Of Southern California Producing a protein in a mammal by injection of a DNA-sequence into the tongue
FR2722208B1 (fr) 1994-07-05 1996-10-04 Inst Nat Sante Rech Med Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US5780448A (en) 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
US5928906A (en) 1996-05-09 1999-07-27 Sequenom, Inc. Process for direct sequencing during template amplification
FR2751345B1 (fr) 1996-07-16 1998-09-18 Univ Paris Curie Lignees d'encapsidation hautement productrices
US5945100A (en) 1996-07-31 1999-08-31 Fbp Corporation Tumor delivery vehicles
AU4645697A (en) 1996-09-11 1998-04-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Aav4 vector and uses thereof
US5981274A (en) 1996-09-18 1999-11-09 Tyrrell; D. Lorne J. Recombinant hepatitis virus vectors
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
US5994624A (en) 1997-10-20 1999-11-30 Cotton Incorporated In planta method for the production of transgenic plants
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US6984517B1 (en) 1998-05-28 2006-01-10 The United States Of America As Represented By The Department Of Health And Human Services AAV5 vector and uses thereof
US6759237B1 (en) 1998-11-05 2004-07-06 The Trustees Of The University Of Pennsylvania Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
WO2000073423A1 (en) 1999-06-01 2000-12-07 Chugai Seiyaku Kabushiki Kaisha Packaging cell
JP2004514407A (ja) 2000-04-28 2004-05-20 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 異種キャプシド中にシュードタイピングされたaav5キャプシドおよびaav5ベクターを含む組換えaavベクター
ATE324321T1 (de) 2000-08-31 2006-05-15 Edwin Lundgren Steuervorrichtung für einen lenkdrachen an einem boot
WO2002053703A2 (en) 2001-01-05 2002-07-11 Children's Hospital, Inc. Aav2 vectors and methods
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
EP1463805B1 (en) 2001-12-17 2014-10-22 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
US7485291B2 (en) 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
PL2657248T3 (pl) 2003-06-19 2017-09-29 Genzyme Corporation Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie
US9441244B2 (en) 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
WO2006138380A2 (en) 2005-06-15 2006-12-28 Massachusetts Institute Of Technology Amine-containing lipids and uses thereof
CA2634046A1 (en) * 2005-12-12 2007-06-21 The University Of North Carolina At Chapel Hill Micrornas that regulate muscle cell proliferation and differentiation
DK2056882T3 (da) * 2006-08-01 2012-11-19 Univ Texas Identifikation af en mikro-rna, som aktiverer ekspression af en tung kæde med beta-myosin
US20100303723A1 (en) 2006-11-20 2010-12-02 Massachusetts Institute Of Technology Drug delivery systems using fc fragments
WO2008124634A1 (en) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Polymer-encapsulated reverse micelles
CA2694928A1 (en) * 2007-07-31 2009-02-05 Board Of Regents, The University Of Texas System Micro-rnas that control myosin expression and myofiber identity
CN102083980A (zh) * 2008-02-21 2011-06-01 得克萨斯系统大学董事会 调节平滑肌增殖和分化的微小rna及其用途
JP2011525794A (ja) * 2008-06-26 2011-09-29 国立大学法人大阪大学 iPS細胞の製造方法および製造キット
WO2010042555A2 (en) 2008-10-06 2010-04-15 The Brigham And Women's Hospital, Inc. Particles with multiple functionalized surface domains
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
CA2807552A1 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP2857499A1 (en) 2010-10-01 2015-04-08 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CA2831392C (en) 2011-03-28 2020-04-28 Massachusetts Institute Of Technology Conjugated lipomers and uses thereof
PT3682905T (pt) 2011-10-03 2022-04-07 Modernatx Inc Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
US9512073B2 (en) 2011-10-27 2016-12-06 Massachusetts Institute Of Technology Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
US9434928B2 (en) 2011-11-23 2016-09-06 Nationwide Children's Hospital, Inc. Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
ES2923757T3 (es) 2011-12-16 2022-09-30 Modernatx Inc Composiciones de ARNm modificado
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
PT2922554T (pt) 2012-11-26 2022-06-28 Modernatx Inc Arn modificado nas porções terminais
JP6726824B2 (ja) * 2013-07-17 2020-07-22 ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション 効率的な遺伝子送達用途のための非毒性hsvベクター及びその製造のための補完細胞
US10538740B2 (en) * 2014-03-20 2020-01-21 Kyoto University Method for sorting cardiomyocytes
JP6836999B2 (ja) 2015-03-24 2021-03-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California アデノ随伴ウイルス変異体及びその使用方法
JP2018513686A (ja) * 2015-04-10 2018-05-31 シンガポール科学技術研究庁Agency for Science, Technology and Research 幹細胞からの機能性細胞の生成
EP3431593A4 (en) * 2016-03-15 2019-11-13 Keio University METHOD FOR THE DIRECT PREPARATION OF A CARDIGENT CELL OR MYOCARDIAL CELL FROM FIBROBLAST

Similar Documents

Publication Publication Date Title
EP1390490B1 (en) Muscle-specific expression vectors
JP2023524291A5 (cg-RX-API-DMAC7.html)
JP2020534314A (ja) 不整脈源性右心室心筋症における電気的機能及び心臓機能並びに心構造を回復するための遺伝子療法戦略
JP2009178593A (ja) 生体組織の細胞治療と電気治療の方法と装置
CN106978415B (zh) 转运rna片段及其应用
Saitoh et al. Expression of myogenic factors in denervated chicken breast muscle: isolation of the chicken Myf5 gene
JP2019506895A (ja) 成人幹細胞から誘導されたペースメーカ細胞及びプルキンエ細胞
CN116218849B (zh) 针对utrophin激活治疗杜氏肌营养不良的sgRNA和应用
CN102127546B (zh) 一种骨骼肌特异性actin启动子及其应用
KR101760618B1 (ko) Sox 유전자가 이입된 비바이러스성 미니써클 벡터 및 이의 제조방법
CN107252491A (zh) 用于治疗心力衰竭的药物及其筛选方法和制备方法
JP2022525193A5 (cg-RX-API-DMAC7.html)
CN113559266A (zh) Ckip-1 3`UTR在预防和/或治疗心力衰竭疾病药物中的应用
JPWO2021020509A5 (cg-RX-API-DMAC7.html)
KR102236843B1 (ko) 새로운 재생 치료제로서의 camkk1
US20060128647A1 (en) Novel oligonucleotides and treating cardiac disorders by using the same
CN101502659A (zh) Krüppel样转录因子4的新用途
WO2021067613A1 (en) Compositions and methods for treating amyotrophic lateral sclerosis
CN110404053A (zh) 短肽mpm在制备用于治疗肌肉细胞分化相关疾病的药物中的应用
JP2022518765A (ja) 心房細動の遺伝子療法による治療
CN111840327B (zh) 治疗糖尿病足的间质干细胞制剂及其应用
US20250360171A1 (en) Chemogenetically gated ion channels and use thereof
CN113956345B (zh) Angpt4蛋白及其编码基因在调控心脏损伤后的修复与再生能力中的应用
US20240301355A1 (en) Methods of inducing cardiac cell proliferation and inducing heart regeneration
WO2024006898A2 (en) Gene therapy of hippo signaling improves heart function in a clinically relevant model